Immunotherapy of cancer
Abstract:
Immunogenic modulators and compositions comprising oligonucleotide agents capable of inhibiting suppression of immune response by reducing expression of one or more gene involved with an immune suppression mechanism.
Public/Granted literature
Information query
Patent Agency Ranking
0/0